Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1983 Jun;2(2):113-28.

The Alza T IPCS 52, a longer acting progesterone IUD: safety and efficacy compared to the TCu22OC and multiload 250 in two randomized multicentre trials. The World Health Organization's special programme of research, development and research training in human reproduction. Task Force on intrauterine devices for fertility regulation

No authors listed
  • PMID: 6367929
Clinical Trial

The Alza T IPCS 52, a longer acting progesterone IUD: safety and efficacy compared to the TCu22OC and multiload 250 in two randomized multicentre trials. The World Health Organization's special programme of research, development and research training in human reproduction. Task Force on intrauterine devices for fertility regulation

No authors listed. Clin Reprod Fertil. 1983 Jun.

Abstract

The longer-acting progesterone-releasing IUD - the Alza T IPCS 52 - was compared to the TCu22OC and Multiload 250 in two randomized trials in 20 centres in 17 countries. There were 2239, 2292 and 1011 insertions respectively. The copper devices had significantly lower medical removal rates and higher continuation rates. The pregnancy rates for the progesterone releasing device were significantly higher after 390 days of use in the interval insertion study and after 870 days in the post abortion insertion study. The Alza T IPCS 52 device achieved only 2 year efficacy rather than the original objective of 3 years.

PubMed Disclaimer